Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

P53 mutation and response to hepatic arterial floxuridine in patients with colorectal liver metastases.

Journal of cancer research and clinical oncology - 1 Nov 2001

Khan Z A, Jonas S K, Feldmann K A, Patel H, Wharton R Q, Tarragona A, Ivison A, Allen-Mersh T G

Abstract excerpt

PURPOSE: To establish the relationship between the number and site of p53 genomic mutations in metastatic colorectal cancer, and the response to hepatic arterial floxuridine. METHODS: Liver metastasis biopsies were collected, at the time of laparotomy for hepatic arterial cannulation. in 28 patients with metachronous colorectal liver metastases. p53 Gene mutations were assessed using reverse transcription, nested...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antimetabolites, Antineoplastic
Share to Codon

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, p53

Share to Liver Neoplasms

Share to Neoplasm Metastasis

Share to Polymorphism, Single-Stranded Conformational

Source

Identifiers

PMID: 11710597
DOI: 10.1007/s004320100248

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

P53 mutation and response to hepatic arterial floxuridine in patients with colorectal liver metastases.PMID 11710597Read ↗

Determination of microsatellite instability, p53 and K-RAS mutations in hepatic metastases from patients with colorectal cancer: relationship with response to 5-fluorouracil and survival.Semantic proximity Read ↗

Mutations in TP53 are a prognostic factor in colorectal hepatic metastases undergoing surgical resection.Semantic proximity Read ↗

p53 mutations as a possible predictor of response to chemotherapy in metastatic colorectal carcinomas.Semantic proximity Read ↗

P53 mutation analysis of colorectal liver metastases: relation to actual survival, angiogenic status, and p53 overexpression.Semantic proximity Read ↗

Methylenetetrahydrofolate reductase gene polymorphisms and response to fluorouracil-based treatment in advanced colorectal cancer patientsSemantic proximity Read ↗

P53 overexpression in colorectal metastases confined to the liver and outcome of liver resection.Semantic proximity Read ↗

K-Ras mutations and treatment outcome in colorectal cancer patients receiving exclusive fluoropyrimidine therapy.Semantic proximity Read ↗

p53 protein overexpression and response to biomodulated 5-fluorouracil chemotherapy in patients with advanced colorectal cancer.Semantic proximity Read ↗

TP53 gene mutations predict the response to neoadjuvant treatment with 5-fluorouracil and mitomycin in locally advanced breast cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.